Loading…
Envoy Medical, Inc. is projected to rise to $0.9391 by 2027, a +37% move from its current price of $0.6833. COCH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.6565 | $0.6832 | $0.711 | -0.02% |
| Jul 14 | $0.6457 | $0.6831 | $0.7227 | -0.03% |
| Jul 15 | $0.6374 | $0.683 | $0.7318 | -0.05% |
| Jul 16 | $0.6306 | $0.6829 | $0.7395 | -0.06% |
| Jul 17 | $0.6246 | $0.6827 | $0.7463 | -0.08% |
| Jul 18 | $0.6192 | $0.6826 | $0.7526 | -0.10% |
| Jul 19 | $0.6143 | $0.6825 | $0.7584 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6143 | $0.6825 | $0.7584 | -0.11% |
| Week 2 | $0.5873 | $0.6817 | $0.7913 | -0.23% |
| Week 3 | $0.5674 | $0.681 | $0.8174 | -0.34% |
| Week 4 | $0.5509 | $0.6802 | $0.8398 | -0.45% |
| Week 5 | $0.5368 | $0.6794 | $0.86 | -0.57% |
| Week 6 | $0.5242 | $0.6787 | $0.8785 | -0.68% |
| Week 7 | $0.5129 | $0.6779 | $0.8959 | -0.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Envoy Medical, Inc. is a healthcare company that focuses on hearing health and provides medical technologies across the hearing loss spectrum. Its product lines include personal sound amplification devices, hearing aids, Esteem fully implanted active middle ear implants, auditory osseointegrated implants, and Acclaim cochlear implants.
The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Envoy Medical, Inc. (COCH) is a healthcare stock with a current price of $0.7087, a market capitalization of $54.58M, and a rank of 4512.
The near-term forecast for 2026 shows an average price of $0.7087 with a neutral sentiment, and a 30-day range from $0.5386 to $0.9325. The 2026 forecast also notes a minimum of $0.39 and a maximum of $0.9343, illustrating tight near-term variability around the current level.
Longer-term projections indicate substantial uplift: the 2030 average price is forecast at $1.11, with a min of $0.7471 and a max of $1.78, yielding a 56.5% ROI and a bullish sentiment. By 2040 the average is $2.07 (min $1.07, max $4.07) with a 192.1% ROI, and by 2050 the average is $3.71 (min $1.67, max $8.20) with a 423.6% ROI and a bullish stance across years.
A major floor 23.4% below — a decisive break under it would weaken the trend.
The nearest floor, 9.3% below — buyers have tended to step in here.
The nearest ceiling, 16.5% above — a clean break opens room to run.
A major ceiling 31.9% above — clearing it would confirm fresh momentum.
Key COCH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COCH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7258 | Sell | $0.7091 | Sell |
| MA 10 | $0.7313 | Sell | $0.7136 | Sell |
| MA 20 | $0.6897 | Sell | $0.7034 | Sell |
| MA 50 | $0.6863 | Sell | $0.6926 | Sell |
| MA 100 | $0.6979 | Sell | $0.7069 | Sell |
| MA 200 | $0.7221 | Sell | $0.8332 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.69 | Neutral |
| Stoch RSI (14) | 19.93 | Buy |
| CCI (20) | -9.69 | Neutral |
| Williams %R (14) | -68.48 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 5.08 | Buy |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 31.52 | Neutral |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 35.89 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 0.69 | Sell |
| ADX (14) | 12.65 | Neutral |
| ATR (14) | 0.03 | Info |
The near-term technical picture is bullish for Envoy Medical, Inc. The sentiment is BULLISH, with RSI14 at 50, indicating neutral momentum within a bullish context. The 50-day simple moving average sits at $0.6848 and the 200-day simple moving average at $0.7266, providing a framework for near-term support and resistance.
Near-term support is at $0.62 and resistance at $0.796, with the 30-day range spanning $0.5386–$0.9325. Annualized volatility stands at 80%, underscoring elevated but manageable variability within the month-long horizon.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.39 | $0.6833 | $0.8882 | 0% | Neutral | |
| $0.7158 | $0.9391 | $1.32 | +37% | Bullish | |
| $0.7232 | $0.9904 | $1.47 | +45% | Bullish | |
| $0.701 | $0.9951 | $1.53 | +46% | Bullish | |
| $0.7179 | $1.05 | $1.67 | +54% | Bullish | |
| $0.6403 | $0.9669 | $1.58 | +42% | Bullish | |
| $0.6799 | $1.06 | $1.77 | +55% | Bullish | |
| $0.7581 | $1.21 | $2.07 | +77% | Bullish | |
| $0.8332 | $1.36 | $2.39 | +99% | Bullish | |
| $0.9967 | $1.67 | $2.98 | +145% | Bullish | |
| $1.02 | $1.91 | $3.70 | +180% | Bullish | |
| $1.54 | $3.43 | $7.43 | +402% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.39 | $0.6833 | $0.7953 | +0.00% |
| August 2026 | $0.5538 | $0.662 | $0.8184 | -3.12% |
| September 2026 | $0.5575 | $0.6733 | $0.8456 | +1.71% |
| October 2026 | $0.527 | $0.6422 | $0.8174 | -4.62% |
| November 2026 | $0.5163 | $0.6339 | $0.8157 | -1.29% |
| December 2026 | $0.5526 | $0.6833 | $0.8882 | +7.79% |
Click any year to see its month-by-month COCH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, COCH is projected to trade between $0.39 and $0.8882, averaging $0.6833 — a potential gain of 0% from today's $0.6833. Price action looks broadly range-bound.
Envoy Medical, Inc.'s 2027 outlook centres on $0.9391, within a $0.7158 to $1.32 range. That is up +37% on the projected 2026 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, COCH could reach as high as $1.47, with a base case around $0.9904 and support toward $0.7232 — roughly +45% from $0.6833. Momentum favours further upside here.
Expect COCH to range from $0.701 to $1.53 through 2029. The $0.9951 average target implies a +46% move from current prices. That is up 0% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The COCH price prediction for 2030 points to an average of $1.05 (low $0.7179, high $1.67) — a potential gain of +54% on today's $0.6833. Momentum favours further upside here.
In 2031, COCH is projected to trade between $0.6403 and $1.58, averaging $0.9669 — a potential gain of +42% from today's $0.6833. That is -8% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Envoy Medical, Inc.'s 2032 outlook centres on $1.06, within a $0.6799 to $1.77 range. That is up +9% on the projected 2031 average. That marks a +55% change versus current levels. Momentum favours further upside here.
By 2033, COCH could reach as high as $2.07, with a base case around $1.21 and support toward $0.7581 — roughly +77% from $0.6833. Buyers look set to stay in control over this stretch.
Expect COCH to range from $0.8332 to $2.39 through 2034. The $1.36 average target implies a +99% move from current prices. That is up +13% on the projected 2033 average. Momentum favours further upside here.
The COCH price prediction for 2035 points to an average of $1.67 (low $0.9967, high $2.98) — a potential gain of +145% on today's $0.6833. Buyers look set to stay in control over this stretch.
In 2040, COCH is projected to trade between $1.02 and $3.70, averaging $1.91 — a potential gain of +180% from today's $0.6833. That is up +14% on the projected 2035 average. Momentum favours further upside here.
Envoy Medical, Inc.'s 2050 outlook centres on $3.43, within a $1.54 to $7.43 range. That is up +79% on the projected 2040 average. That marks a +402% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in COCH today (≈ 1,463.486024 COCH) could be worth
$5,022.48
+$4,022.48 (+402%) by 2050 · US Dollar
Based on the average projected COCH price of $3.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in COCHwould be worth at today's price.
$1,000 invested in COCH on Jul 10, 2025 (≈ 694.444417 COCH) would be worth
$474.51
-$525.49 (-52.5%) today · 0.47× · US Dollar
Based on a COCH entry price of $1.44 vs. today's $0.6833.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.752 | $908.64 | -9.1% |
| 1 month ago | $0.655 | $1,043.21 | +4.3% |
| 3 months ago | $0.612 | $1,116.5 | +11.7% |
| 6 months ago | $0.712 | $959.69 | -4.0% |
| 1 year ago | $1.44 | $474.51 | -52.5% |
| All time (5.0y) ago | $9.66 | $70.73 | -92.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COCH forecast.
Our base-case forecast reaches $1.40 around 2035.
Implied market cap at $1.40: $107.83M
The multi-year forecast paints a clear bullish trajectory for Envoy Medical, Inc., with the average price steadily rising through the coming years. The 2026 average is $0.7087, then 2027 averages $0.9902 and 2030 averages $1.11, signaling a continued upward path toward the long horizon.
Key longer-term milestones show notable upside: in 2030 the min is $0.7471, the max is $1.78, and the ROI is 56.5% with a bullish sentiment. In 2040 the min is $1.07, the average is $2.07, the max is $4.07, and the ROI is 192.1% with a bullish sentiment. In 2050 the min is $1.67, the average is $3.71, the max is $8.20, and the ROI is 423.6% with a bullish sentiment.
These are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $1.11, a min of $0.7471, a max of $1.78, a 56.5% ROI, and a bullish sentiment.
The forecast indicates neutral sentiment in 2026 with an average of $0.7087 and a 0% ROI, followed by bullish sentiment from 2027 onward, with ROIs of 39.7% in 2027, 47.5% in 2028, 48.2% in 2029, 56.5% in 2030, 43.8% in 2031, 57.8% in 2032, 82.1% in 2033, 106.6% in 2034, 154% in 2035, 192.1% in 2040, and 423.6% in 2050.
Yes. The forecast shows max values above $2 in several years: 2033 max $2.25, 2034 max $2.60, 2035 max $3.26, 2040 max $4.07, and 2050 max $8.20.
Current price is $0.7087 and market capitalization is $54.58M. The rank is 4512.
The near-term picture is bullish. RSI14 is 50, SMA50 is $0.6848, SMA200 is $0.7266, with near-term support at $0.62 and resistance at $0.796. The 30-day range is $0.5386–$0.9325, and annualized volatility is 80%.
Envoy Medical, Inc. Community Discussion
0Share your Envoy Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.